Showing 5,807 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Cardiovascular disease

What's the connection between HIV and high blood pressure?

Editor's pick
American Heart Association News
23 May 2018
Treatment for women

Dolutegravir may cause birth defects, European Medicines Agency warns

News
21 May 2018
Pharmaceutical industry

AIDS Healthcare Foundation files two lawsuits against Gilead

Editor's pick
The Bay Area Reporter
21 May 2018
Transgender people

Viral suppression among transgender women is improving, but results are still below the national average

Editor's pick
The Black AIDS Institute
21 May 2018
Treatment for women

Potential safety issue affecting women living with HIV using dolutegravir at the time of conception

Editor's pick
World Health Organization
21 May 2018
Conception

Why the Dolutegravir Pregnancy Warning is Important — and What We Should Do Now

Editor's pick
NEJM Journal Watch
21 May 2018
Conception

New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir

Editor's pick
European Medicines Agency
21 May 2018
Hepatitis C treatment

Do direct acting antivirals cure chronic hepatitis C?

Editor's pick
BMJ
18 May 2018
Menopause

High prevalence of menopausal symptoms in women living with HIV, but very few receive treatments for them

News
17 May 2018
Improving HIV care

HIV Care Gaps of Less Than 9 Months Do Not Worsen Patients

Editor's pick
MD Magazine
16 May 2018
Treatment guidelines

Phase 3 registrational data is not sufficient for roll-out of new ARVs in low- and middle-income countries

Editor's pick
HIV i-Base
15 May 2018
Side effects

Is Gilead’s Entire HIV Enterprise Built on a False Promise?

Editor's pick
Poz
10 May 2018
HIV treatment

Stribild may address 'urgent need' for HIV-2 treatment

Editor's pick
Healio
8 May 2018
Epidemiology & behaviour

Computer Models Are Changing How We Craft HIV-AIDS Policies

Editor's pick
Healthcare Analytics News
4 May 2018
Men who have sex with men (MSM)

Sexual Minorities Uganda Statement on Postponed First Annual Conference on Key and Priority Populations

Editor's pick
Sexual Minorities Uganda
2 May 2018
Starting treatment

State-of-the-art HIV drug could curb HIV transmission, improve survival in India

Editor's pick
Science Daily
1 May 2018
Side effects

Meta-analysis of dolutegravir in naive, experienced and switch studies

Editor's pick
HIV i-Base
30 April 2018
Finance & funding

NHS England saved £10 million by switching to generic anti-HIV drugs in 2016

News
30 April 2018
New & experimental HIV treatments

European CHMP Adopts Positive Opinion for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide)

Editor's pick
Gilead press release
27 April 2018
TB treatment

Smartphone app keeps an 'eye' on daily tuberculosis therapy

Editor's pick
Eurekalert Inf Dis
27 April 2018
How HIV works

New findings on inflammation & how it affects people with HIV

Editor's pick
BETA blog
27 April 2018
Young people

What are the outcomes for adults who were born with HIV?

News
25 April 2018
Bad science & bogus treatments

Russian Government Drafts Bill To Fight AIDS Denial

Editor's pick
Radio Free Europe
23 April 2018
Treatment guidelines

Latest DHHS Guidelines for Initial HIV Therapy Now Include 5 Choices — But Really 2 Are Best

Editor's pick
NEJM Journal Watch
23 April 2018